Published in BMC Med on October 23, 2006
Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med (2008) 13.35
Mitigation measures for pandemic influenza in Italy: an individual based model considering different scenarios. PLoS One (2008) 2.54
Effectiveness of interventions to reduce contact rates during a simulated influenza pandemic. Emerg Infect Dis (2007) 1.59
Combination strategies for pandemic influenza response - a systematic review of mathematical modeling studies. BMC Med (2009) 1.29
Epidemic modeling with discrete-space scheduled walkers: extensions and research opportunities. BMC Public Health (2009) 1.22
The effects of school closures on influenza outbreaks and pandemics: systematic review of simulation studies. PLoS One (2014) 1.10
Modeling seasonal influenza outbreak in a closed college campus: impact of pre-season vaccination, in-season vaccination and holidays/breaks. PLoS One (2010) 1.06
Does the effectiveness of control measures depend on the influenza pandemic profile? PLoS One (2008) 1.05
Mutations in haemagglutinin that affect receptor binding and pH stability increase replication of a PR8 influenza virus with H5 HA in the upper respiratory tract of ferrets and may contribute to transmissibility. J Gen Virol (2013) 1.05
Behavioural responses to influenza pandemics: what do we know? PLoS Curr (2009) 1.00
National pandemic influenza preparedness planning. Influenza Other Respir Viruses (2009) 0.97
Planning for the next influenza H1N1 season: a modelling study. BMC Infect Dis (2010) 0.96
Pandemic influenza, reopening schools, and returning to work. Emerg Infect Dis (2008) 0.95
Epidemiological consequences of household-based antiviral prophylaxis for pandemic influenza. J R Soc Interface (2013) 0.91
Scenarios of diffusion and control of an influenza pandemic in Italy. Epidemiol Infect (2008) 0.86
Nonpharmaceutical Interventions for Military Populations During Pandemic Influenza. Turk Silahli Kuvvetleri Koruyucu Hekim Bul (2007) 0.83
An optimal control theory approach to non-pharmaceutical interventions. BMC Infect Dis (2010) 0.83
Breaking the waves: modelling the potential impact of public health measures to defer the epidemic peak of novel influenza A/H1N1. PLoS One (2009) 0.80
Design of non-pharmaceutical intervention strategies for pandemic influenza outbreaks. BMC Public Health (2014) 0.77
Prioritization of delayed vaccination for pandemic influenza. Math Biosci Eng (2011) 0.77
Evaluating temporal factors in combined interventions of workforce shift and school closure for mitigating the spread of influenza. PLoS One (2012) 0.77
Mitigating effects of vaccination on influenza outbreaks given constraints in stockpile size and daily administration capacity. BMC Infect Dis (2011) 0.76
Pandemism of swine flu and its prospective drug therapy. Eur J Clin Microbiol Infect Dis (2012) 0.76
Recalibrating disease parameters for increasing realism in modeling epidemics in closed settings. BMC Infect Dis (2016) 0.75
Visual analytics of geo-social interaction patterns for epidemic control. Int J Health Geogr (2016) 0.75
Evaluation of Influenza Vaccination Efficacy: A Universal Epidemic Model. Biomed Res Int (2016) 0.75
Multi-scale modeling for the transmission of influenza and the evaluation of interventions toward it. Sci Rep (2015) 0.75
Integrating Transgenic Vector Manipulation with Clinical Interventions to Manage Vector-Borne Diseases. PLoS Comput Biol (2016) 0.75
Influences on influenza transmission within terminal based on hierarchical structure of personal contact network. BMC Public Health (2015) 0.75
An operational epidemiological model for calibrating agent-based simulations of pandemic influenza outbreaks. Health Care Manag Sci (2014) 0.75
Collective dynamics of 'small-world' networks. Nature (1998) 98.45
Emergence of scaling in random networks Science (1999) 89.38
Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature (2005) 30.92
Strategies for mitigating an influenza pandemic. Nature (2006) 25.20
Containing pandemic influenza at the source. Science (2005) 23.95
Mitigation strategies for pandemic influenza in the United States. Proc Natl Acad Sci U S A (2006) 17.88
Transmissibility of 1918 pandemic influenza. Nature (2004) 16.14
Modelling disease outbreaks in realistic urban social networks. Nature (2004) 14.54
Superspreading and the effect of individual variation on disease emergence. Nature (2005) 14.01
Containing pandemic influenza with antiviral agents. Am J Epidemiol (2004) 12.82
Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N Engl J Med (2006) 9.73
Heterogeneities in the transmission of infectious agents: implications for the design of control programs. Proc Natl Acad Sci U S A (1997) 9.07
Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet (2004) 8.62
Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis (1998) 8.51
Neuraminidase inhibitors for influenza. N Engl J Med (2005) 7.79
Avian flu: isolation of drug-resistant H5N1 virus. Nature (2005) 6.66
The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med (1995) 6.16
Zipf distribution of U.S. firm sizes. Science (2001) 6.02
A Bayesian MCMC approach to study transmission of influenza: application to household longitudinal data. Stat Med (2004) 5.90
Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial. Lancet (2006) 5.72
Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest (1998) 5.70
The role of evolution in the emergence of infectious diseases. Nature (2003) 5.65
Risk factors of influenza transmission in households. Br J Gen Pract (2004) 5.25
Emerging infections: pandemic influenza. Epidemiol Rev (1996) 4.85
Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA (1999) 4.71
Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis. J Infect Dis (2004) 4.31
Properties of highly clustered networks. Phys Rev E Stat Nonlin Soft Matter Phys (2003) 3.05
Assessment of the protective efficacy of vaccines against common diseases using case-control and cohort studies. Int J Epidemiol (1984) 2.96
Public health. Will vaccines be available for the next influenza pandemic? Science (2004) 2.74
Influenza burden of illness: estimates from a national prospective survey of household contacts in France. Arch Intern Med (2002) 2.48
Epidemiology: dimensions of superspreading. Nature (2005) 2.47
A study of illness in a group of Cleveland families. XVII. The occurrence of Asian influenza. Am J Hyg (1958) 2.19
Nasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo-controlled trial of intravenous zanamivir treatment. J Infect Dis (1999) 2.03
Safety and efficacy of intravenous zanamivir in preventing experimental human influenza A virus infection. Antimicrob Agents Chemother (1999) 1.49
Oral oseltamivir in human experimental influenza B infection. Antivir Ther (2000) 1.39
Limits to forecasting precision for outbreaks of directly transmitted diseases. PLoS Med (2005) 1.26
Comparison of infection rats and severity of illness for influenza A subtypes H1N1 and H3N2. J Infect Dis (1985) 1.26
Effect of rimantadine treatment on clinical manifestations and otologic complications in adults experimentally infected with influenza A (H1N1) virus. J Infect Dis (1998) 0.98
Effects of the neuraminidase inhibitor zanamavir on otologic manifestations of experimental human influenza. J Infect Dis (1997) 0.97
An accurate and interpretable model for siRNA efficacy prediction. BMC Bioinformatics (2006) 2.46
DSIR: assessing the design of highly potent siRNA by testing a set of cancer-relevant target genes. PLoS One (2012) 0.85
Toxicity assays in nanodrops combining bioassay and morphometric endpoints. PLoS One (2007) 0.78
A Bayesian active learning strategy for sequential experimental design in systems biology. BMC Syst Biol (2014) 0.77
Accelerating parallel transmit array B1 mapping in high field MRI with slice undersampling and interpolation by kriging. IEEE Trans Med Imaging (2014) 0.75
Geostatistical modeling of sound propagation: Principles and a field application experiment. J Acoust Soc Am (2009) 0.75